Bionas and PRIMACYT to cooperate on cell-based assay for prediction of hepatotoxic effects of drugs and chemicals
Primary human hepatocytes, provided by PRIMACYT, are cultivated directly on collagen-coated Bionas® metabolic chips. The chips are then placed into the Bionas analyzing system to evaluate the effect of test compounds. After a recovery period the hepatocytes can be re-used for further experiments.
Predicting liver toxicity is a major concern of the pharmaceutical industry and non-immortalized primary human hepatocytes can be used as biosensors for the analysis of drugs, food additives and chemicals.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.